The intrinsic modulatory mechanism of cytokines secreted by CD4+ TH cells influencing ECM remodeling would be our study field in the future, which is a crucial dimension to explain the correlation of the TME with prognosis in breast cancer and find potential combined therapies in the clinic. The gene discussed is CD4; the disease is breast carcinoma.